DBV Technologies | DBVT - 貿易債務者





貿易債務者 変化する 日付
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amarin USD 126.83M 477K 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
DBV Technologies USD 15.1M 1.05M 2026-03
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
Incyte USD 1.13B 73.7M 2026-06
Insmed USD 178.55M 37.7M 2026-03
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Neurocrine Biosciences USD 887M 118.9M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 312M 38.2M 2026-03